Literature DB >> 3219234

Evolution of the structural proteins of human immunodeficiency virus: selective constraints on nucleotide substitution.

A L Brown1, P Monaghan.   

Abstract

We have estimated the frequency of synonymous (KS) and amino acid replacement nucleotide substitutions (KA) among gag and env genes of published HIV sequences. The ratio of KS to KA can be used as an indicator of the intensity of the selective constraints on the amino acid sequence of a protein. By this approach we have shown that for both gp120 and gp41, the rate of change in amino acid sequence relative to the overall rate of change in nucleotide sequence is higher than for any other protein yet analyzed. The gag proteins p15 and p17 evolve slightly less rapidly, but p24 is relatively strongly conserved. We have compared the env gene of HIV with those of two other retroviruses for which appropriate data are available. In neither murine leukemia virus nor feline leukemia virus do the envelope glycoproteins evolve particularly rapidly. These results suggest that HIV is unusual among retroviruses in that both gp120 and gp41 are evolving under extremely weak selective constraints relative to the rest of the viral genome; accordingly, much of the observed variation may be selectively neutral.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3219234     DOI: 10.1089/aid.1988.4.399

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  18 in total

1.  Reevaluation of amino acid variability of the human immunodeficiency virus type 1 gp120 envelope glycoprotein and prediction of new discontinuous epitopes.

Authors:  Y Yamaguchi-Kabata; T Gojobori
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

2.  Convergent and divergent sequence evolution in the surface envelope glycoprotein of human immunodeficiency virus type 1 within a single infected patient.

Authors:  E C Holmes; L Q Zhang; P Simmonds; C A Ludlam; A J Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

3.  Host-specific driving force in human immunodeficiency virus type 1 evolution in vivo.

Authors:  L Zhang; R S Diaz; D D Ho; J W Mosley; M P Busch; A Mayer
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

4.  Mutational trends in V3 loop protein sequences observed in different genetic lineages of human immunodeficiency virus type 1.

Authors:  B T Korber; K MacInnes; R F Smith; G Myers
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

5.  Human immunodeficiency virus type 1 evolution in vivo tracked by DNA heteroduplex mobility assays.

Authors:  E L Delwart; H W Sheppard; B D Walker; J Goudsmit; J I Mullins
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

6.  Analysis of sequence diversity in hypervariable regions of the external glycoprotein of human immunodeficiency virus type 1.

Authors:  P Simmonds; P Balfe; C A Ludlam; J O Bishop; A J Brown
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

7.  Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection.

Authors:  L Q Zhang; P MacKenzie; A Cleland; E C Holmes; A J Brown; P Simmonds
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

8.  Genetically related human immunodeficiency virus type 1 in three adults of a family with no identified risk factor for intrafamilial transmission.

Authors:  L Bélec; A Si Mohamed; M C Müller-Trutwin; J Gilquin; L Gutmann; M Safar; F Barré-Sinoussi; M D Kazatchkine
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

9.  Evolution in a chronic RNA virus infection: selection on HTLV-I tax protein differs between healthy carriers and patients with tropical spastic paraparesis.

Authors:  S Niewiesk; C R Bangham
Journal:  J Mol Evol       Date:  1996-04       Impact factor: 2.395

10.  Human immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers.

Authors:  P Simmonds; P Balfe; J F Peutherer; C A Ludlam; J O Bishop; A J Brown
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.